Please login to the form below

Not currently logged in
Email:
Password:

GSK's Lawson elected PAGB president

He will help lead OTC trade body after departure of Novartis' David Barnett
pagb Carlton Lawson

The Proprietary Association of Great Britain (PAGB), which represents OTC companies in the UK, has elected Carlton Lawson of GlaxoSmithKline (GSK) as its new president.

On March 3 Lawson, who is general manager of GSK's consumer health business in the UK and Ireland, will take over from Novartis' David Barnett who moves to a new position in Latin America.

Lawson was only appointed to his current GSK position last year having previously served as global business lead in oral heath at the healthcare giant.

This followed a career that included senior sales and brand roles at Warner Lamber, Pfizer and Johnson & Johnson. He has experience with the PAGB too, being elected vice president in 2007.

Matthew Speers, chief executive of the PAGB, said he was “looking forward to working with Lawson”.

“Having served on the PAGB board previously when he was general manager at Johnson & Johnson, he has in-depth knowledge of PAGB and this past experience will be a great asset in helping drive forward PAGB's work programme, particularly the better regulation agenda,” said Speers.

26th February 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...